SCHEMBL22319082

SCHEMBL22319082

CC(C)(C)[Si](Cc1ccccc1)C(C)(C)C

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 1/20 0.44
TAAR1 Q96RJ0 1/20 0.44
TP53 P04637 1/20 0.42
CYP2D6 P10635 2/20 0.41
LMNA P02545 1/20 0.41
CALM1 P0DP23 1/20 0.39
CYP3A4 P08684 2/20 0.38
CYP1A2 P05177 1/20 0.38
PRMT1 Q99873 1/20 0.38
TSHR P16473 4/20 0.37
ALDH1A1 P00352 3/20 0.37
TRPA1 O75762 2/20 0.36
IDO1 P14902 1/20 0.36
LOXL2 Q9Y4K0 1/20 0.36
KDM4E B2RXH2 2/20 0.36
TDP1 Q9NUW8 1/20 0.36
MAPT P10636 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL496611 0.80 SLC6A2 (0.44) SLC6A2TAAR1TP53CYP2D6LMNA
SCHEMBL476127 0.70 PTGS1 (0.48) SLC6A2TAAR1TP53CALM1CYP3A4
SCHEMBL6960730 0.70 TP53 (0.48) SLC6A2TAAR1TP53CALM1CYP3A4
SCHEMBL28365326 0.70 SLC6A2 (0.50) SLC6A2TAAR1TP53CYP2D6LMNA
SCHEMBL41195 0.69 CALM1 (0.50) TAAR1TP53CALM1TSHRALDH1A1
SCHEMBL16298659 0.67 TP53 (0.43) TP53CALM1TSHRALDH1A1TRPA1
SCHEMBL9075638 0.67 TP53 (0.50) SLC6A2TAAR1TP53CALM1CYP3A4
SCHEMBL8575145 0.67 TP53 (0.50) SLC6A2TAAR1TP53CALM1CYP3A4
SCHEMBL347187 0.65 SLC6A2 (0.64) SLC6A2TAAR1TP53CYP2D6LMNA
SCHEMBL703317 0.65 CALM1 (0.45) TAAR1TP53CALM1TSHRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11993629-B2 Method for producing peptide compound NISSAN CHEMICAL CORPORATION (JP) 2024-05-28 US claimed
CN-111164092-B Process for producing peptide compound 日产化学株式会社 2023-12-26 CN claimed
EP-3922638-A1 METHOD FOR PRODUCING PEPTIDE COMPOUND Nissan Chemical Corporation (JP) 2021-12-15 EP claimed
CN-113366011-A Method for producing peptide compound 日产化学株式会社 2021-09-07 CN claimed
US-20200291061-A1 METHOD FOR PRODUCING PEPTIDE COMPOUND NISSAN CHEMICAL CORPORATION (JP) 2020-09-17 US claimed
WO-2020162393-A1 METHOD FOR PRODUCING PEPTIDE COMPOUND 日産化学株式会社 2020-08-13 WO claimed
EP-3693377-A1 METHOD FOR PRODUCING PEPTIDE COMPOUND Nissan Chemical Corporation (JP) 2020-08-12 EP claimed
CN-111164092-A Method for producing peptide compound 日产化学株式会社 2020-05-15 CN claimed
US-11993629-B2 Method for producing peptide compound NISSAN CHEMICAL CORPORATION (JP) 2024-05-28 US disclosed
CN-111164092-B Process for producing peptide compound 日产化学株式会社 2023-12-26 CN disclosed
EP-3922638-A1 METHOD FOR PRODUCING PEPTIDE COMPOUND Nissan Chemical Corporation (JP) 2021-12-15 EP disclosed
CN-113366011-A Method for producing peptide compound 日产化学株式会社 2021-09-07 CN disclosed
US-20200291061-A1 METHOD FOR PRODUCING PEPTIDE COMPOUND NISSAN CHEMICAL CORPORATION (JP) 2020-09-17 US disclosed
WO-2020162393-A1 METHOD FOR PRODUCING PEPTIDE COMPOUND 日産化学株式会社 2020-08-13 WO disclosed
EP-3693377-A1 METHOD FOR PRODUCING PEPTIDE COMPOUND Nissan Chemical Corporation (JP) 2020-08-12 EP disclosed
CN-111164092-A Method for producing peptide compound 日产化学株式会社 2020-05-15 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200291061-A1 METHOD FOR PRODUCING PEPTIDE COMPOUND VIP, NGLY1, IAPP SLC6A2 4310/4885TAAR1 2433/4885TP53 879/4885
US-11993629-B2 Method for producing peptide compound VIP, NGLY1, IAPP SLC6A2 4128/4885TAAR1 1929/4885TP53 1742/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.